/NDVAF
NDVAF Stock - Indiva Limited
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.02+6.19%
+$0.00 (+6.19%) • Jun 13
71
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.69
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.97
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.02
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for NDVAF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.02 – $0.02
TARGET (TP)$0.03
STOP LOSS$0.02
RISK/REWARD1:3.3
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.58
52W High$0.02
52W Low$0.02
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $37.57M | $34.40M | $32.47M | $14.65M | $923,862 |
| Gross Profit | $10.52M | $8.15M | $6.85M | $-874,000 | $54,362 |
| Gross Margin | 28.0% | 23.7% | 21.1% | -6.0% | 5.9% |
| Operating Income | $-2,125,000 | $-6,098,000 | $-5,547,000 | $-8,886,000 | $-10,097,000 |
| Net Income | $-4,918,000 | $-10,932,000 | $-15,217,000 | $-15,423,000 | $-11,398,000 |
| Net Margin | -13.1% | -31.8% | -46.9% | -105.3% | -1233.7% |
| EPS | $-0.03 | $-0.08 | $-0.11 | $-0.16 | $-0.14 |
Company Overview
Indiva Limited engages in the production, processing, and sale of cannabis and cannabis related products in Canada. It offers pre-rolls, flower, capsules, and edible and extract products under the INDIVA and Artisan Batch brands, as well as provides production and manufacturing services to peer entities. The company produces and distributes the Bhang Chocolate, Wana Sour Gummies, Slow Ride Bakery Cookies, Jewels Chewable Tablets, Ruby Cannabis Sugar, Grön edibles, and Dime Industries vape products through license agreements and partnerships. Indiva Limited is based in Ottawa, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
NDVAFBeat Rate
14%
Last 7 quarters
Avg Surprise
-97.3%
EPS vs Estimate
Beats / Misses
1/6
Last 12 quarters
Latest EPS
$-0.01
Q2 2024
EPS Surprise History
Q3 22
-157.7%
$-0.02vs$-0.01
Q4 22
-176.6%
$-0.02vs$-0.01
Q2 23
-171.0%
$-0.02vs$-0.01
Q2 23
-100.0%
$-0.02vs$-0.01
Q3 23
No data
Q4 23
-100.0%
$-0.00vs$-0.00
Q4 23
No data
Q2 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Sep 22, 2025 | — | — | — | — |
Q2 2025 | Jun 23, 2025 | — | — | — | — |
Q2 2025 | May 29, 2025 | — | — | — | — |
Q1 2025 | Mar 26, 2025 | — | — | — | — |
Q4 2024 | Dec 27, 2024 | — | — | — | — |
Q3 2024 | Sep 27, 2024 | — | — | — | — |
Q2 2024 | Apr 25, 2024 | — | $-0.01 | — | — |
Q4 2023 | Dec 30, 2023 | — | $-0.00 | — | — |
Q4 2023 | Nov 21, 2023 | $-0.00 | $-0.00 | -100.0% | ✗ MISS |
Q3 2023 | Aug 29, 2023 | — | $-0.01 | — | — |
Q2 2023 | May 16, 2023 | $-0.01 | $-0.02 | -100.0% | ✗ MISS |
Q2 2023 | Apr 18, 2023 | $-0.01 | $-0.02 | -171.0% | ✗ MISS |
Q4 2022 | Nov 22, 2022 | $-0.01 | $-0.02 | -176.6% | ✗ MISS |
Q3 2022 | Aug 16, 2022 | $-0.01 | $-0.02 | -157.7% | ✗ MISS |
Q2 2022 | May 18, 2022 | $-0.02 | $-0.02 | -0.1% | ✗ MISS |
Q2 2022 | Apr 26, 2022 | $-0.04 | $-0.03 | +24.1% | ✓ BEAT |
Q4 2021 | Nov 16, 2021 | — | $-0.05 | — | — |
Q3 2021 | Aug 24, 2021 | — | $-0.01 | — | — |
Q2 2021 | May 31, 2021 | — | $-0.03 | — | — |
Q2 2021 | May 13, 2021 | — | $-0.05 | — | — |
Latest News
Loading news...
Frequently Asked Questions about NDVAF
What is NDVAF's current stock price?
Indiva Limited (NDVAF) is currently trading at $0.02 per share. The stock has moved +6.19% today.
What is the analyst price target for NDVAF?
No analyst price targets are currently available for this stock.
What sector is Indiva Limited in?
Indiva Limited operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is NDVAF's market cap?
Indiva Limited has a market capitalization of $0.00 billion, making it a small-cap company.
Does NDVAF pay dividends?
No, Indiva Limited does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACRDF
Acreage Holdings, Inc.
$0.12
Mkt Cap: $0.0B
ACRHF
Acreage Holdings, Inc.
$0.00
Mkt Cap: $0.0B
CHNC
China Infrastructure Construction Corp.
$0.00
Mkt Cap: $0.0B
DOGP
Dogecoin Cash, Inc.
$0.02
Mkt Cap: $0.0B
GHSI
Guardion Health Sciences, Inc.
$3.25
Mkt Cap: $0.0B
HDRPF
Epsilon Healthcare Limited
$0.00
Mkt Cap: $0.0B
HERTF
Heritage Cannabis Holdings Corp.
$0.00
Mkt Cap: $0.0B
IVITF
Invictus MD Strategies Corp.
$0.00
Mkt Cap: $0.0B
PXMVF
Pixium Vision S.A.
$1.50
Mkt Cap: $0.0B
VVCIF
VIVO Cannabis Inc.
$0.02
Mkt Cap: $0.0B
Explore stocks similar to NDVAF for comparison